title: Effects of maternal ritodrine administration on neonatal renal function.
abstract: Because of its effects on the cardiovascular and renin-angiotensin systems and on fluid and electrolyte homeostasis, maternal administration of ritodrine to inhibit preterm labor may cause significant alterations in renal function in the newborn infant. We determined inulin clearance, plasma renin activity, urinary arginine vasopressin excretion, and serum and urine electrolyte concentrations and osmolalities at 12 to 36 hours of life and at 6 days of life in 15 infants whose mothers had received ritodrine and in 15 infants whose mothers did not (control infants). At the time of each study, plasma ritodrine concentrations were obtained in the infants whose mothers received ritodrine. The infants whose mothers had received ritodrine had significantly lower inulin clearances and higher plasma renin activity and urinary arginine vasopressin excretion on day 1 but not on day 6. Gestational age was inversely correlated with plasma ritodrine concentration, plasma renin activity, and urinary arginine vasopressin excretion. There were no overt clinical signs of renal failure in any of the infants, and no differences in serum and urine electrolyte values, osmolality, fractional sodium excretion, or urine flow rate were observed between the groups.
mesh_terms: D001127:Arginine Vasopressin / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007231:Infant, Newborn; D007444:Inulin / Q000097:blood / Q000652:urine; D008099:Liver / Q000187:drug effects*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011412:Propanolamines / Q000009:adverse effects*; D012083:Renin / Q000097:blood; D012312:Ritodrine / Q000009:adverse effects* / Q000097:blood; D012964:Sodium / Q000652:urine
chemical_list: D011412:Propanolamines; D001127:Arginine Vasopressin; D007444:Inulin; D012964:Sodium; D012083:Renin; D012312:Ritodrine